Diversify Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Buy
18,594
+4,978
+37% +$612K 0.04% 346
2026
Q1
$1.54M Buy
13,616
+4,933
+57% +$689K 0.03% 459
2025
Q4
$1.45M Buy
8,683
+743
+9% +$116K 0.07% 255
2025
Q3
$1.19M Buy
7,940
+2,865
+56% +$348K 0.07% 253
2025
Q2
$616K Buy
5,075
+1,358
+37% +$173K 0.04% 339
2025
Q1
$518K Buy
3,717
+375
+11% +$57.7K 0.04% 357
2024
Q4
$518K Buy
3,342
+1,423
+74% +$204K 0.04% 346
2024
Q3
$264K Buy
1,919
+307
+19% +$44K 0.03% 419
2024
Q2
$261K Buy
+1,612
New +$253K 0.03% 377

Other funds holding RGEN

Diversify Wealth Management's RGEN Position: Q2 2026 in Review

Diversify Wealth Management increased its Repligen (RGEN) stake by 37% in Q2 2026, buying an estimated $612K and bringing the position to 18,594 shares worth $2.44M. The position accounts for 0.04% of the portfolio, ranked #346.

Diversify Wealth Management first reported a position in RGEN in Q2 2024 and has held it in 9 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Diversify Wealth Management held 18,594 shares of Repligen worth $2.44M as of Q2 2026.
  • Diversify Wealth Management bought 4,978 Repligen shares in Q2 2026, an estimated $612K.
  • Repligen made up 0.04% of Diversify Wealth Management's portfolio in Q2 2026, its #346 holding.
  • Diversify Wealth Management first reported a position in Repligen in Q2 2024 and has held it in 9 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.